1887

oa SA Pharmaceutical Journal - Aspirin : unsurpassed in prevention of heart attack and stroke in wide range of patients : press release

 

Abstract

Extracted from text ... 51 SA Pharmaceutical Journal - April 2006 PRESS RELEASE Data from a long-term study released today solidifies aspirin's role as the preeminent antiplatelet therapy in the prevention of heart attack and stroke. The results of the Clopidogrel for High Atherothrombotic Risk and Ischaemic Stabilisation, Management, and Avoidance (CHARISMA) trial, which were presented recently at the 55th Annual Scientific Session of the American College of Cardiology in Atlanta, Georgia, USA, and published online in an advance issue of the New England Journal of Medicine1, highlight the primacy of aspirin among antiplatelet agents and adds to the robust body of evidence supporting ..

Loading

Article metrics loading...

/content/mp_sapj/73/3/EJC81467
2006-04-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error